KRAS is the best-known oncogene with the most frequent mutation rate among all cancers and is considered the most common oncogenic gene driver in human cancers, and it is most commonly seen in CRC, non-small cell lung cancer (NSCLC), and pancreatic cancer [5]. This evidence concerns the gene KRAS and cancer.